The cellular sites of clearance and degradation of the pentraxin plasma proteins, C-reactive protein, the classical acute phase reactant, and serum amyloid P component (SAP), a universal constituent of amyloid deposits, were sought using the ligand 'MI-yramine cellobiose (TC) which is substantially retained within the cells in which catabolism takes place. Pentraxins labeled with '"I-TC showed the same in vitro and in vivo ligand binding and the same in vivo plasma to as the directly iodinated proteins and the native unlabeled pentraxins, indicating that their mode of clearance was likely to be physiological. After intravenous injection into mice and rabbits of human C-reactive protein, human SAP, and mouse SAP, each labeled with '"I-TC, most of the radioactivity remaining in the body at 24 h was located in hepatocytes. None was detected in other liver cells, and only traces were present in other viscera; the rest was in the carcass, representing intact pentraxins in the blood and extravascular compartment, and escaped label which had not yet been excreted. Hepatocytes are thus the single major site of pentraxin clearance and catabolism in vivo. This is consistent with the observation that SAP that has localized to amyloid deposits persists there and is not degraded. (J. CliU. Invest. 1994. 94:1390-1396
Introduction
The human pentraxin plasma proteins are C-reactive protein (CRP),1 the classical acute phase reactant, and serum amyloid P component (SAP), a universal constituent of amyloid deposits (1) . The three dimensional protein structure (2) and the complete glycostructure of SAP (3) have been characterized lately in detail, and the plasma turnover and distribution of both CRP and SAP in humans in health and disease have been reported (4, 5) . However, their normal sites of clearance and catabolism have not been identified although this aspect of their metabolism is of fundamental and clinical interest for both proteins. For example, firstly, the rapid production and clearance of CRP have made it the marker of choice for monitoring of the acute phase response and it is widely used in clinical practice for determining the presence, extent, and activity of many infective and inflammatory disorders (6) . Secondly, several lines of evidence suggest that SAP may participate in the persistence of amyloid deposits in vivo: SAP levels correlate with amyloidogenesis in experimental animal models (7) (8) (9) , SAP is inherently proteinase resistant (10) , and SAP in human amyloid deposits in vivo is neither degraded ( 11 ) nor modified (3 ) . The route of catabolism of SAP may thus be important in amyloidogenesis.
CRP and SAP in the circulation are produced exclusively by hepatocytes and both turn over rapidly with plasma t1/ values of 19 and 24 h, respectively (4, 5) . In studies of normal subjects using '23I-labeled pentraxins, no tissue deposition or localization of either protein has been observed, nor any deposition of CRP in vivo in a variety of diseases (4) . In contrast, SAP binds to all types of amyloid fibrils, and its in vivo deposition in amyloid is both readily demonstrable and exceptionally useful in clinical practice (5, 12, 13) . However, tracer studies with proteins directly labeled by oxidative iodination are not informative about the sites of clearance and catabolism because proteolysis is usually extremely rapid and the released iodotyrosine rapidly leaves the catabolizing cell and is excreted in the urine. We have therefore used pentraxins labeled with the nondegradable marker '"I-tyramine cellobiose (TC) in the trapped catabolism procedure (14) and found that hepatocytes are the major site of uptake and breakdown of these proteins. established by demonstration of its retained ability to undergo calciumdependent binding to phosphoethanolamine-Sepharose (18) . Blood clearance studies. Mice received 10-20 jig of labeled protein (0.2-0.5 0Ci) intravenously via the lateral tail vein and were bled 100 jIl from the tail 2 min later to provide a zero time sample. Further tail vein bleeds were taken at intervals up to 24 h and individually weighed, and total radioactivity present corrected for the mass of blood present was expressed as a percentage of that present in the original sample. Rabbits received 20-50 jig of labeled protein (0.5-1.0 MCi) via the left marginal ear vein and were bled from the right ear 5 min later for the zero time sample. Subsequent bleeds at intervals up to 24 h were weighed and counted, and the percentage of remaining activity was calculated. Tissue localization. At the end of each clearance study the animals were killed, mice by cervical dislocation, and rabbits by intravenous injection of 60 mg of sodium pentobarbitone, and the organs were individually removed, weighed, and counted. The eviscerated carcasses of the mice were also counted so that total remaining radioactivity could be calculated, but this was not technically possible with the rabbits.
Histology. Tissue was fixed immediately after death in 10% formaldehyde in 0.075 M sodium phosphate buffer, pH 7.0. The cellular and tissue location of '25I-TC activity was determined by autoradiography using the dipping film method (21); K2 liquid film emulsion (size A) was from Ilford Ltd. (Cheshire, United Kingdom). Morphological details were confirmed in serial sections stained with hematoxylin and eosin, and amyloid was identified by its pathognomonic green birefringence in polarized light after staining with Congo red (22) .
Results
Integrity of '251-TC-labeled pentraxins. Human SAP, mouse SAP, and human CRP that had been covalently labeled with "II-TC displayed precisely the same in vitro binding to immobilized phosphoethanolamine as directly iodinated pentraxins. Furthermore, the in vivo clearance of the '"I-TC pentraxins was the same as that of their directly labeled counterparts, both in mice and in rabbits (Fig. 1) . Human SAP was cleared more rapidly than mouse SAP in normal mice, as reported previously (20, 23) , and all proteins were cleared more rapidly in mice than in rabbits, but labeling with TC had no effect. Furthermore, human CRP was cleared at the same rate in normal rabbits and in animals mounting a major acute phase response. The clearance patterns observed here ( Fig. 1) were essentially the same as reported previously (20, 23, 24) .
The capacity of TC-labeled SAP, both human and mouse, to localize in vivo to amyloid deposits in mice was identical to that of the directly iodinated proteins. There was the same accelerated clearance of labeled SAP from the plasma of amyloidotic mice compared with the normal controls (Fig. 2, A and B). There was also greater retention of lzsI-TC activity in the liver and spleen (Fig. 3, A and B) , the sites of amyloid accumulation, than in normal animals. This enhanced organ localization corresponded to SAP deposition in the amyloid itself, demonstrated by autoradiography (Fig. 4) , and was precisely as reported before with directly labeled SAP (23).
Labeling with 1251I-TC thus did not alter the in vivo behavior or handling of the pentraxins compared with the directly labeled proteins, and their central functional property of ligand-binding, both in vitro and in vivo, was retained. We have reported previously that the behavior of pentraxins labeled by direct oxidative iodination, as described here, is identical to that of the native unaltered proteins (4, 11) , and the 125I-TC-labeled pentraxins were therefore suitable tracers for identification of the physiological cellular sites of pentraxin catabolism in vivo.
Distribution of activity from '251-TC SAP in normal mice. Despite marked trapping and retention of radioactivity after injection of SAP labeled with "lI-TC, compared with directly iodinated SAP, some of the injected dose had been excreted by 24 h. Most of the amount remaining was located in the liver with only traces in any of the other viscera (Fig. 3) . Activity in the carcass reflects both intact protein in the blood and extravascular compartment and labeled breakdown products that was more activity in the liver and less in the carcass than in animals receiving mouse SAP. This corresponds to the more rapid clearance of the xenogeneic compared with the isogeneic pentraxin ( Fig. 1) . Distribution of activity from I25ITC SAP in amyloidotic mice. The results in amyloidotic mice were similar to those in normal animals except that there was more activity in the liver and spleen, the sites of amyloid deposition, reflecting binding of intact SAP molecules to amyloid deposits as well as trapped catabolism (Fig. 3) . There was also correspondingly less activity remaining in the carcass, reflecting the more rapid plasma clearance ( Figs. 1 and 2) .
Distribution of activity from '25I-TC human CRP in mice. At 24 h after injection, 70% of the retained activity was in the liver, and only traces were present in other viscera. A small proportion remained in the carcass, representing undegraded protein and unexcreted breakdown products in the blood and extravascular compartment (Table I) .
Distribution of l2sI-TC human CRP in rabbits. counted. Most was present in the liver, and there were only trace quantities in the other viscera (Table II) . This pattern was unaffected by the presence of an intercurrent acute phase response.
Cellular location ofpentraxin catabolism. Autoradiographs of histological sections of the livers of normal rabbits and mice which had received '"I-TC-labeled pentraxins showed activity only in hepatocytes. In the rabbits injected with '25I-TC human CRP, the labeled cells were all in zone 1, close to the portal tracts, but in mice receiving mouse SAP or human pentraxins there was no zonal localization (Fig. 4) . No activity was associated with Kupffer cells, nor was any signal detectable in autoradiographs of other tissues. In amyloidotic mice which had been injected with '25I-TC SAP, tracer was present in hepatic and splenic amyloid deposits as well as in hepatocytes (Fig. 4) .
Discussion
The trapped catabolism method for identifying the cellular site of protein breakdown uses a covalent label that cannot be degraded and that is retained within the cells responsible for its cleavage from the protein. Tyramine cellobiose is currently the best available material for this purpose (14) . Cellobiose is not metabolized by mammalian cells and is trapped within lysosomes, while the tyramine conjugated to it provides a convenient structure for radioiodination and for covalent coupling to protein. The radioactive degradation products of catabolism of '"I-TC-protein conjugates are thus retained within the catabolizing cells and provide a cumulative index of tissue uptake. Such retention is, of course, not absolute, and we elected to monitor distribution at 24 h after injection of tracer rather than at later times when, despite catabolism of a greater proportion of the conjugate, there would also be more leakage of product.
A critical criterion for physiological interpretation of the results is that labeling with '"I-TC should not affect the properties, behavior, or handling of the protein. We therefore established that our 1"I-TC pentraxins were the same as their directly iodinated counterparts with respect to in vitro ligand binding and in vivo handling. Furthermore, we showed that the '"I-TC SAP preparations retained in full the capacity of directly iodinated and indeed native unlabeled SAP to localize and bind to amyloid deposits in vivo. Pentraxins oxidatively iodinated using N-bromosuccinimide, as described here, are indistinguishable from the native proteins with respect to ligand binding and in vivo clearance (4, 11) . We are therefore confident that the distribution and catabolism of the '251-TC pentraxins accurately reflect the physiological handling of native pentraxins. The results obtained with mouse SAP in the mouse and with human pentraxins in mice and rabbits were the same. There was major uptake in the liver and very little indeed in any other visceral organs. The proportion retained in the liver was highest when the protein in question was most rapidly cleared from the (30) . Apolipoprotein Al is predominantly cleared and catabolized in the kidneys (27) , and this is the exclusive site for lysozyme (31) (10, 32) , and in amyloidosis, SAP, which has localized to the deposits as a result of its calcium-dependent binding to the amyloid fibrils, persists there for prolonged periods without being catabolized or altered in any way (3, 1 1) . This phenomenon, which may be important in the persistence of amyloid deposits in vivo (2, 33) , is entirely compatible with the present demonstration that hepatocytes are the only cells in which significant catabolism of pentraxins occurs. Of interest, the liver is usually involved late in systemic amyloidosis, even when the precursor of the fibril protein is of liver origin, raising the possibility that proximity to the cells responsible for SAP catabolism may alter the dynamic equilibrium of the SAP-amyloid fibril interaction so as to reduce amyloid deposition or persistence. However, even if this speculation is correct, it does not always apply since many patients with either acquired or hereditary amyloidosis have massive hepatic amyloid deposition despite apparently normal catabolism of circulating SAP (11, (34) (35) (36) . The mechanisms responsible for recognition and uptake of circulating pentraxins destined for degradation by the hepatocytes are not known. Human CRP is not glycosylated, and a protein recognition mechanism must therefore be involved. Human and mouse SAP are both glycosylated, and we have shown lately that desialylation of human SAP causes it to be very rapidly cleared in the liver via the asialoglycoprotein receptor, both in mice and humans (3) . However, this may not be the normal physiological pathway for SAP clearance because complete blockade of the asialoglycoprotein receptor in mice in vivo did not retard the clearance of normally sialylated SAP (3) . Whatever the recognition and uptake mechanisms may be, they evidently have high capacity. The plasma t1,2 of human CRP in humans is independent of the circulating CRP level (4) , and in the present study the plasma clearance and liver uptake of human CRP in rabbits were unaffected by an intercurrent acute phase response of rabbit CRP. Similarly, our previous studies indicated that the plasma clearance of mouse SAP, which unlike human SAP (37) is a major acute phase protein (38), is also independent of the concentration in the circulation (39) .
